The American Cancer Society (ACS) has set an aggressive goal to achieve an 80 percent uptake rate among American children with two doses human papillomavirus (HPV) vaccine by 2026. To gain that coverage, 14 million more preteen children would need to complete the two-dose series, for a total of 57.62 million doses above and beyond the number of vaccinations given to date.1 HPV vaccine is one of the most expensive vaccines on the CDC recommended childhood vaccine schedule, costing a pricey $168 to $204 per dose, with Merck being the sole producer of HPV vaccine (Gardasil) in the U.S.2
Immediately after Gardasil vaccine was licensed in 2006, Gardasil’s potential for causing serious side effects began to be has been widely reported.10 The serious complications of HPV vaccination continue to be reported today in countries around the world.11
Although U.S. health officials have continued to deny a causal connection, Japanese researchers have pointed out that the temporal association with post- Gardasil clinical symptoms such as “chronic regional pain syndrome, orthostatic intolerance, and/or cognitive dysfunction” suggests a causal relationship with the vaccine.13 Other health issues associated with HPV vaccination include nervous and immune system disorders such as postural orthostatic tachycardia syndrome (POTS), chronic fatigue syndrome, blood clots, acute respiratory failure and cardiac arrest…
Read the entire article HERE. The authors are Kate Raines and Barbara Loe Fisher.
As always, ask for the vaccine package inserts and go over them. Make an informed decision. The following quote applies:
“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce